Liver transplantation linked to lower antibody, T-cell response to COVID-19 vaccine

LONDON — Patients who received a liver transplant had significantly reduced antibody and T-cell responses to SARS-CoV-2 vaccination compared with healthy controls, according to research presented at the International Liver Congress.“Emerging data have demonstrated suboptimal immune responses to SARS-CoV-2 vaccination in immunosuppressed cohorts,” Thomas Marjot, a clinical research training fellow at the Oxford Liver Unit at Oxford University Hospitals NHS Foundation Trust, and colleagues wrote. “However, unified assessments comparing multiple vaccine platforms acrossRead More